CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy

NCT02693080 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Malignant Lung Neoplasm
Metastatic Malignant Neoplasm in the Lung
Non-Small Cell Lung Carcinoma
Stage IV Lung Cancer

Interventions

DEVICE: CAPP-Seq
DRUG: Isovue-200
RADIATION: Computed Tomography Perfusion Imaging

Sponsor

Stanford University